Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation

Authors:
  • CGCelia Grosskreutz
    Celia Grosskreutz
  • SFSander S. Florman
    Sander S. Florman
  • GGGabriel E. Gondolesi
    Gabriel E. Gondolesi
  • SSSanjay Sharma
    Sanjay Sharma
  • SKStuart S. Kaufman
    Stuart S. Kaufman
  • TFThomas M. Fishbein
    Thomas M. Fishbein

Abstract
Calcineurin inhibitor-induced thrombotic microangiopathy (TMA) has been described in up to 14% of solid-organ transplant recipients. Sirolimus has recently been described in two reports in association with TMA. Sirolimus is known to potentiate cyclosporine-induced nephrotoxicity, but such effect has not been shown with tacrolimus. We report two intestinal transplant patients who developed TMA while on a tacrolimus and sirolimus immunosuppressive regimen. This syndrome appeared soon after institution of or increase in sirolimus dosage and improved only after this medication was discontinued.

This publication has 9 references indexed in Scilit: